t2cure Appoints Dr Petra Rueck and Susanne Knigge as Co-CEOs

12-Jan-2010 - Germany

t2cure GmbH announced that it has appointed Dr. Petra Rueck and Mrs. Susanne Knigge to Co-CEO’s, effective January 1, 2010. Dr. Manfred Ruediger has laid down his assignment as CEO and Managing Director of t2cure GmbH to join Life Sciences Partners, the European life sciences venture group, as a partner. The Company also announced that its lead product is now available for patients suffering from cardiovascular disease.

Before being appointed to CEO, Dr. Petra Rueck served as Head Clinical Operations of t2cure since 2007. Susanne Knigge was a managing director of t2cure between 2005 and 2008 and supported the Company as legal counsel from 2008 to 2009. Dr. Ruediger was CEO of t2cure from 2006 through 2009 and will remain a shareholder and a consultant to the Company.

Other news from the department people

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance